Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent: 2 patents

Readers on

mendeley: 4 Mendeley

Summary Patents

So far, Altmetric has seen 2 patents that reference this research output.

ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF

Application EP-3383914-A4

European Patent Office

METHOD AND BIOMARKERS FOR PREDICTING EFFICACY AND EVALUATION OF AN OX40 AGONIST TREATMENT

Application WO-2016073380-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.